Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 6/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 2/20 | 0.33 |
| ▸ | DRD2 | P14416 | 2/20 | 0.33 |
| ▸ | HTR7 | P34969 | 2/20 | 0.33 |
| ▸ | HTR6 | P50406 | 2/20 | 0.33 |
| ▸ | KDM5A | P29375 | 1/20 | 0.33 |
| ▸ | HPGDS | O60760 | 1/20 | 0.33 |
| ▸ | SLC6A12 | P48065 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 2/20 | 0.32 |
| ▸ | CCR8 | P51685 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8667143 | 0.96 | CCR3 (0.40) | CCR3KDM4EMEN1KMT2AHTR1A | |
| SCHEMBL8717987 | 0.84 | CCR3 (0.44) | CCR3KDM4EMEN1KMT2AHTR1A | |
| SCHEMBL8712541 | 0.84 | CCR3 (0.44) | CCR3KDM4EMEN1KMT2AHTR1A | |
| SCHEMBL8665520 | 0.81 | CCR3 (0.42) | CCR3KDM4EHTR1ADRD2HTR7 | |
| SCHEMBL8665531 | 0.80 | CCR3 (0.41) | CCR3KDM4EHTR1ADRD2HTR7 | |
| SCHEMBL8653118 | 0.79 | CCR3 (0.43) | CCR3KDM4EMEN1KMT2AHTR1A | |
| SCHEMBL8479999 | 0.74 | CCR3 (0.51) | CCR3KDM4EMEN1KMT2AHTR1A | |
| SCHEMBL8479942 | 0.74 | CCR3 (0.51) | CCR3MEN1KMT2AHTR1ADRD2 | |
| SCHEMBL8485545 | 0.72 | NPSR1 (0.40) | CCR3MEN1KMT2ASLC6A12 | |
| SCHEMBL8524381 | 0.72 | CCR3 (0.42) | CCR3KDM4EMEN1KMT2AHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5883099-A | TREATMENT OF ATHERSCLEROSIS, PANCREATITIS OBESITY OR HYPERGLYCEMIA | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-03-16 | — | — | US | disclosed |
| US-H1729-H | Method for preparing compounds employing solid phase synthesis and novel linker-resin | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-05-05 | — | — | US | disclosed |
| US-5739135-A | PREVENTING OR TREATING ATHEROSCLEROSIS, PANCREATITIS SECONDARY TO HYPERTRIGLYCERIDEMIA, HYPERGLYCEMIA, OBESITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-04-14 | — | — | US | disclosed |